safety of retatrutide Explained: Mechanism, Phase 3 TRIUMPH-1 Results, Safety, and Future Potential – C2 Peptides Unapproved weight-loss drug "reta" sold
Description
No safety issues were identified in the CRL, nor did the FDA request any additional studies be conducted, according to Endpoints News
Tzaban, R.H
It was a signal
The significant reduction in urinary oxalate excretion after weight loss through GLP-based therapies could possibly be attributed to decreased intake of oxalate and oxalate precursors or to reduced hepatic oxalate synthesis
Although semaglutide doesnt have any known drug interactions, youll want to check with your doctor before starting any medication to manage bloating
Ask whether the medication is FDA-approved or compounded, which pharmacy prepares or dispenses it, what clinical evaluation is required, how contraindications are screened, and how dosing and side effects are monitored
